Jason C Hsu

16PUBLICATIONS
54CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesObstetrics and gynaecologyPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 23, 2026
Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis.

|Jun 05, 2026
Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis Using Electronic Health Records: Multicenter Cohort Study.

|Apr 18, 2026
Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study.

|Mar 31, 2026
Downstream Treatment Burden and Health-Care Utilization Following Initiation of GLP-1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes.

Yazan Alhamdan, Jason C Hsu, Christine Y Lu

|Mar 05, 2026
Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.

Seonji Kim, Jimyung Park, Hsin Yi Chen

|Dec 04, 2024
The protective role of anti-parkinsonian drugs in pancreatic cancer risk: A comprehensive case-control study in Taiwan.

Hsuan-Chia Yang, Wen-Chi Chou, Phung-Anh Nguyen

Pageof 3

Frequent Collaborators

6 joint publications

Phung-Anh Nguyen

4 joint publications

Chih-Wei Huang

3 joint publications

Hsuan-Chia Yang

3 joint publications

Christine Y Lu